|
|
 |
|
Viewing report
|
|
|
|
Australia Pharmaceuticals and Healthcare Report Q1 2009
Business Monitor International, Feb 2009, Pages: 99
This Australia Pharmaceuticals and Healthcare Report provides independent forecasts and competitive intelligence on Australia's pharmaceuticals and healthcare industry.
For this update of BMI’s Australia Pharmaceuticals & Healthcare Report, we have extended our market expenditure forecast through to 2013. We have also changed our sources for data to the Organisation for Economic Co-operation and Development (OECD), Synovate Aztec and the Association of the European Self Medication Society (AESGP). These market research bodies have demonstrated both credibility and reliability. We calculate that sales of pharmaceuticals in Australia surpassed the US$7bn milestone in 2008.
In September 2008, Family First Senator Steve Fielding voted with the opposition to defeat the federal government's bill that planned changes to Australian government agency Medicare's levy surcharge thresholds. The bill aimed to raise the income levels at which the Medicare levy surcharge starts for taxpayers not having private health insurance from AUD50,000 (US$45,288) to AUD100,000 (US$90,575) for singles, and from AUD100,000 (US$90,575) to AUD150,000 (US$135,863) for couples. In October 2008, the Combined Pensioners and Superannuants Association (CPSA) called on the Australian government to raise the pharmaceutical grant to help senior citizens finding it difficult to fill prescriptions. The request highlighted the fact that the rising cost of drugs and an increase in prescription co-payment levels mean that a large number of pensioners are not able to meet the expense of essential medication.
The cost of prescription drugs increased by AUD1.60 (US$1.45) to AUD32.90 (US$29.80) on January 1 2009. Pensioners now have to buy 60 scripts, an increase of two, while general patients will have to purchase 38 scripts, before they qualify for the safety net that provides the chronically ill with free medicines.
In June 2008, researchers from the Universities of Newcastle and Queensland found that almost one in 12 young women in the country was consuming antidepressants. This makes the medicine category the most frequently taken in the 18 to 23 years range, more than oral contraceptives and adrenergic inhalants for the treatment of asthma. BMI's Burden of Disease Database (BoDD) reveals that depression resulted in the loss of 205,127 disability-adjusted life years (DALYs) in Australia during 2007. This equates to 33.8% of the total neuropsychiatric condition burden. The burden of depression will increase marginally through to 2020, and then fall slowly through to 2030. Given that males are less susceptible to depression
than women, we calculate that three fifths of this burden can be attributed to females.
Customers who bought this item also bought
Australia Pharmaceuticals and Healthcare Report Q4 2009
Australia Pharmaceuticals and Healthcare Report Q3 2008
Australia Pharmaceuticals and Healthcare Report Q4 2008
The Pharmaceutical Market: Australia
Australia Pharmaceuticals and Healthcare Report Q2 2008
Australia Pharmaceuticals & Healthcare Report Q1 2008
OTC Healthcare in Australia to 2010
OTC Pharmaceuticals in Australia
Bangladesh Pharmaceuticals and Healthcare Report Q1 2009
Opportunities and Challenges for Generic Drugs in Australia
The Medical Device Market: Australia
Bangladesh Pharmaceuticals and Healthcare Report Q3 2009
|
|
|
|
